Cargando…
A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
Investigating secular trends of ocular cancer registration in Iran. After acquiring Iranian national population-based cancer registry data, trends of age-standardised incidence rates (ASIR) of ocular cancers and annual percent changes (APC) between 2004 and 2016 were analysed in age groups, gender,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852578/ https://www.ncbi.nlm.nih.gov/pubmed/36658192 http://dx.doi.org/10.1038/s41598-022-26349-x |
_version_ | 1784872676641210368 |
---|---|
author | Abolhosseini, Mohammad Khorrami, Zahra Safi, Sare Akbari, Mohammad Esmaeil Moshtaghion, Seyed Mohamadmehdi Mohammadi, Seyed Farzad Kanavi, Mozhgan Rezaei Karimi, Saeed |
author_facet | Abolhosseini, Mohammad Khorrami, Zahra Safi, Sare Akbari, Mohammad Esmaeil Moshtaghion, Seyed Mohamadmehdi Mohammadi, Seyed Farzad Kanavi, Mozhgan Rezaei Karimi, Saeed |
author_sort | Abolhosseini, Mohammad |
collection | PubMed |
description | Investigating secular trends of ocular cancer registration in Iran. After acquiring Iranian national population-based cancer registry data, trends of age-standardised incidence rates (ASIR) of ocular cancers and annual percent changes (APC) between 2004 and 2016 were analysed in age groups, gender, topography and morphology types with joinpoint regression analysis. Age, period, and cohort effects on incidence rates were estimated by age–period–cohort model. Geographic distribution of ASIR was assessed using GIS. Overall ASIR of ocular cancers was 16.04/100,000 (95% CI 15.77–16.32). Joinpoint regression analysis showed a significant increase of ASIR between 2004 and 2009 for males (APC = 5.5, 95% CI 0.9–10.2), ages over 50 years (APC = 5.2, 1.2–9.4), skin/canthus/adnexal cancers (APC = 4.2, 0.8–7.7), and carcinomas/adenocarcinomas (APC = 4.3, 0.6–8.1); however, between 2009 and 2016 a declining trend was observed in all investigated variables. ASIR of retinoblastoma was significantly increased (averaged APC = 20.7, 9–33.7) between 2004 and 2016. age–period–cohort analyses showed that incidence rates of ocular cancers significantly increased with aging, time periods, and birth cohort effects (p < 0.001). ASIR varied from 6.7/100,000 to 21.7/100,000 in Iran. Excepting retinoblastoma, all ocular cancer incidence trends were downward over a 13-year period; however, it was increasing between 2004 and 2009 cancer. ASIR was significant aging in Iran. |
format | Online Article Text |
id | pubmed-9852578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-98525782023-01-21 A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 Abolhosseini, Mohammad Khorrami, Zahra Safi, Sare Akbari, Mohammad Esmaeil Moshtaghion, Seyed Mohamadmehdi Mohammadi, Seyed Farzad Kanavi, Mozhgan Rezaei Karimi, Saeed Sci Rep Article Investigating secular trends of ocular cancer registration in Iran. After acquiring Iranian national population-based cancer registry data, trends of age-standardised incidence rates (ASIR) of ocular cancers and annual percent changes (APC) between 2004 and 2016 were analysed in age groups, gender, topography and morphology types with joinpoint regression analysis. Age, period, and cohort effects on incidence rates were estimated by age–period–cohort model. Geographic distribution of ASIR was assessed using GIS. Overall ASIR of ocular cancers was 16.04/100,000 (95% CI 15.77–16.32). Joinpoint regression analysis showed a significant increase of ASIR between 2004 and 2009 for males (APC = 5.5, 95% CI 0.9–10.2), ages over 50 years (APC = 5.2, 1.2–9.4), skin/canthus/adnexal cancers (APC = 4.2, 0.8–7.7), and carcinomas/adenocarcinomas (APC = 4.3, 0.6–8.1); however, between 2009 and 2016 a declining trend was observed in all investigated variables. ASIR of retinoblastoma was significantly increased (averaged APC = 20.7, 9–33.7) between 2004 and 2016. age–period–cohort analyses showed that incidence rates of ocular cancers significantly increased with aging, time periods, and birth cohort effects (p < 0.001). ASIR varied from 6.7/100,000 to 21.7/100,000 in Iran. Excepting retinoblastoma, all ocular cancer incidence trends were downward over a 13-year period; however, it was increasing between 2004 and 2009 cancer. ASIR was significant aging in Iran. Nature Publishing Group UK 2023-01-19 /pmc/articles/PMC9852578/ /pubmed/36658192 http://dx.doi.org/10.1038/s41598-022-26349-x Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Abolhosseini, Mohammad Khorrami, Zahra Safi, Sare Akbari, Mohammad Esmaeil Moshtaghion, Seyed Mohamadmehdi Mohammadi, Seyed Farzad Kanavi, Mozhgan Rezaei Karimi, Saeed A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 |
title | A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 |
title_full | A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 |
title_fullStr | A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 |
title_full_unstemmed | A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 |
title_short | A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 |
title_sort | joinpoint and age–period–cohort analysis of ocular cancer secular trends in iran from 2004 to 2016 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852578/ https://www.ncbi.nlm.nih.gov/pubmed/36658192 http://dx.doi.org/10.1038/s41598-022-26349-x |
work_keys_str_mv | AT abolhosseinimohammad ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT khorramizahra ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT safisare ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT akbarimohammadesmaeil ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT moshtaghionseyedmohamadmehdi ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT mohammadiseyedfarzad ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT kanavimozhganrezaei ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT karimisaeed ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT abolhosseinimohammad joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT khorramizahra joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT safisare joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT akbarimohammadesmaeil joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT moshtaghionseyedmohamadmehdi joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT mohammadiseyedfarzad joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT kanavimozhganrezaei joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 AT karimisaeed joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016 |